iRemedy Supply

11/14/2025

At iRemedy, we’re committed to supporting patients, caregivers, and the healthcare professionals who fight this disease every day.

Today our team wore blue to raise awareness and stand in solidarity with the millions of Americans living with diabetes, including families within our own iRemedy community.

Access to reliable, high-quality medical supplies is essential in chronic disease care — and we’re proud to support that mission.

11/10/2025

This should concern every American.

Even when U.S. companies like Oxford Pharmaceutical can produce high-quality medicines at competitive prices, they’re being undercut by foreign manufacturers subsidized by governments overseas — and too often, those same importers are winning U.S. government contracts.

That system has to end.

We need targeted trade enforcement, AI-driven transparency, and federal procurement reform that makes U.S.-made medicines the default, not the exception.

When given fair access, American manufacturers can compete and win.

Watch the full Senate hearing: https://www.aging.senate.gov/hearings/bad-medicine-closing-loopholes-that-kill-american-patients

11/07/2025

Here’s the truth — America already has the technology to make generics profitably without raising costs for patients.

What’s missing is fair competition.

Foreign governments have learned how to weaponize commodity pricing, forcing American manufacturers to fight uphill battles.

It’s time to restore balance — and give domestic producers the chance to compete on a level field.

🎥 Watch the full Senate hearing: https://www.aging.senate.gov/hearings/bad-medicine-closing-loopholes-that-kill-american-patients

11/07/2025

Our CEO, Tony Paquin, testified before the U.S. Senate Special Committee on Aging, addressing America’s overreliance on foreign-made medicines and the urgent need to strengthen our domestic pharmaceutical supply chain.

Watch his full opening statement here: https://www.youtube.com/watch?v=x2MkdyPnU7Q&t=4s

In his testimony before the U.S. Senate Special Committee on Aging, Tony Paquin, CEO of iRemedy, shares his firsthand experience inside the global pharmaceut...

11/05/2025

“Country of origin labeling and quality checks are important — but they’re only band-aids.”

In his Senate testimony, our CEO outlined the path forward:
➡️ Reshore America’s supply chain
➡️ Invest in next-generation manufacturing technologies
➡️ Fast-track permits and cut delays

Nearly all active pharmaceutical ingredients (APIs) come from overseas — mostly China. Restoring control of our medicine supply isn’t just an economic issue; it’s a matter of national security.

🎥 Watch the full Senate hearing: https://www.aging.senate.gov/hearings/bad-medicine-closing-loopholes-that-kill-american-patients

11/04/2025

Excited to announce our new collaboration with UPS Healthcare - delivering an integrated solution that connects healthcare manufacturers directly to world-class logistics & fulfillment.

Together, we’re helping small and mid-sized healthcare businesses scale efficiently, reduce integration costs, and strengthen supply chain resilience across the U.S.

Learn more: http://ups.com/us/en/healthcare/learning-center/articles/iremedy-joint-solution-guide

MedicalDevice

11/03/2025

During Operation Warp Speed, iRemedy helped deliver more than 1 billion medical items — critical to America’s response.

What our CEO witnessed firsthand revealed a deeper problem:
⚠️ China seized 40% of U.S.-bound medical supplies.
⚠️ Fake FDA certificates flooded the market.
⚠️ Bad actors exploited a broken system.

When 90% of generics come from overseas, our nation’s health depends on others’ permission.

It’s time for accountability, transparency, and unannounced FDA inspections abroad — just like at home.

🎥 Watch the full Senate testimony: https://www.aging.senate.gov/hearings/bad-medicine-closing-loopholes-that-kill-american-patients

10/31/2025

POV: When healthcare innovation meets Halloween imagination 🎃

The iRemedy team brought creativity, collaboration, and a little spooky fun to the office today!

Here’s to great work and great culture — all year round. 👻

10/31/2025

Spirits were high at iRemedy today as our team brought some Halloween fun to the workplace!
Innovation, teamwork — and just the right amount of spooky energy. 👻

10/29/2025

Far too much of our essential medicine production has been ceded to foreign adversaries…” 🇺🇸

In his testimony before the U.S. Senate Special Committee on Aging, iRemedy CEO Tony Paquin outlined the urgent need to restore control of America’s medical supply chain.

🎥 Watch his opening statement and hear why this message matters now more than ever:
https://www.aging.senate.gov/hearings/bad-medicine-closing-loopholes-that-kill-american-patients

10/27/2025

“25 years I’ve worked in healthcare technology, logistics, and distribution…” — Tony Paquin, CEO, iRemedy Healthcare

In his opening statement before the U.S. Senate Special Committee on Aging, Tony shared insights from decades of experience in healthcare innovation emphasizing the urgent need to modernize and secure America’s medical supply chain.

🎥 Watch the full hearing: https://www.aging.senate.gov/hearings/bad-medicine-closing-loopholes-that-kill-american-patients

10/24/2025

Team iRemedy shows up in pink for a reason.Because awareness matters. Because lives matter.